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Robert LoweAbstract
In the second of our series of articles celebrating peer
reviewers, we talk to Robert Lowe, who is a Lecturer
in computational biology at Queen Mary University of
London, UK, and a valued reviewer for Genome Biology. There are a number of key challenges in epigenetic re-
search that will hopefully start to be addressed in thePlease tell us about your current research
interests
I use computational tools to better understand epigen-
etic processes. The starting point for this work has been
the identification of biological processes that involve
clear and robust differences in epigenetic marks.
In 2015 [1], we identified senescence-associated differen-
tially methylated positions (senDMPs) in human mammary
epithelial cells. Interestingly, we found that these senDMPs
could be reversed by transfecting cultures with small-
interfering RNAs (siRNAs) targeting p16. This therefore
provides us with an opportunity to investigate the dynamics
of DNA methylation through this process. In particular, we
are interested in how regions of CpGs become methylated
and unmethylated. Previously, Landan and colleagues [2]
have shown that development of differential methylation
occurs through a stochastic process during in vitro evolu-
tion of immortalized fibroblasts, and Landau et al. [3] have
shown similar stochastically disordered methylation in ma-
lignant cells of chronic lymphocytic leukaemia, which was
associated with adverse clinical outcome. The question
therefore remains—do all regions of differential methylation
occur through stochastic processes?
We are also interested in the interplay between epigen-
etic modifications, such as histone modification and DNA
methylation, as well as between epigenetic modifications
and genetics. We recently identified [4] variability in DNA
methylation in response to early-life nutrition at ribosomal
DNA (rDNA), which is restricted to rDNA copies associ-
ated with a specific genetic variant.
Our aim is to build computational models of these in-
teresting biological processes that we hope will provide aCorrespondence: r.lowe@qmul.ac.uk
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can then test.What are your predictions for your field over the
next 5 years?
next 5 years.
We need to understand the contribution that epigenetic
variation actually plays in the various biological processes
that we see correlations with, such as cancer, ageing and
cellular differentiation. It is possible that a number of
these epigenetic marks are present owing to genetic vari-
ation or are recruited after transcriptional changes occur
and hence do not result in any functional consequence.
With the use of CRISPER-Cas9 technologies and the pos-
sibility of directly changing DNA methylation, it should be
possible to interrogate how important a role epigenetics
actually plays.
Additionally, we need to start to understand the import-
ant context of where these epigenetic variations occur.
The function of the same epigenetic marks can be differ-
ent at different locations within the genome, and therefore
understanding what the defining features of these loca-
tions are is important. For example, it is becoming ever
more clear that the three-dimensional structure of the
genome allows for the interpretation of seemingly long-
range interactions by means of the looping of the genome.
Finally, as it becomes increasingly cost effective to pro-
file many different biological processes, including the
transcriptome, the metabolome and the proteome, it will
become necessary to incorporate these datasets together.
This could provide a unique opportunity to begin to
understand the potential effects and causes of the vari-
ation in the epigenetic marks.What motivates you to provide peer review for
journals?
It is vitally important that the scientific community upholds
a form of quality control in which work can only be pub-
lished with the appropriate data from which conclusions
are drawn. While peer review is clearly not perfect, I believele is distributed under the terms of the Creative Commons Attribution 4.0
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therefore I see it as an important part of my job. An add-
itional motivator is remembering the many hours that have
been volunteered by my scientific colleagues in providing
peer review for my own papers.What changes, if any, would you make to the
current system of peer review?
The main change I would make to peer review is to make
the process double-blind and not allow the reviewers to
know the identity of the authors. I think that the process
should be based purely on the work presented, and I think
that reviewers can often be persuaded to accept or reject
an article based on who is submitting it.
I would also be interested in the ability to submit
questions to the authors in a less formal way. For
example, it should be possible during the review
process to contact the authors and ask for clarifica-
tion on small points that can often be crucial for the
understanding of the paper. This would also provide
the opportunity for a detailed discussion on a much
quicker timescale than is currently possible through
the review and resubmit process. The reviewer could
then, based on this detailed discussion, submit a
formalised question in which the authors would be
able to respond effectively as they would understand
fully the aim of the question.
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